Since the establishment of beta-blockers and renin-angiotensin-aldosterone system inhibitors as chronic heart failure treatment agents that can improve long-term prognosis, no novel drugs as a breakthrough for chronic heart failure have emerged. This evidence concerns the gene REN and congestive heart failure.